Skip to main content
Clinical Trials/NCT05355038
NCT05355038
Completed
Not Applicable

Effect of Lifestyle Modification on Pregnancy Outcomes for Pregnant Women With Gestational Diabetes: an Evidence Based.

Cairo University1 site in 1 country150 target enrollmentNovember 11, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
GDM
Sponsor
Cairo University
Enrollment
150
Locations
1
Primary Endpoint
effect of lifestyle modification among GDM on pregnancy outcome
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Effect of lifestyle modification on pregnancy outcome for pregnant women with GDM

Detailed Description

evaluate the effect of lifestyle modification on pregnancy outcome among GDM women. Primary outcomes: excessive gestational weight gain, uncontrolled blood glucose level, PIH, polyhydromnios, oligohydrominos, recurrent monilia infection and urinary tract infection , intra uterine fetal death (IUFD), intra uterine growth restriction (IUGR), premature preterm rupture of membrane and Diabetic ketoacidosis. Secondary outcomes: preterm labor, caesarian section, neonatal hypoglycemia, stillbirth, respiratory distress syndrome, small for gestational age (SGA), large for gestational age (LGA) ,neonatal intensive care unit (NICU) and failure to initiate or maintain breast feeding.

Registry
clinicaltrials.gov
Start Date
November 11, 2020
End Date
March 21, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Basma Said Mahmoud Elgamasy

assistant lecture in maternal and newborn health nursing

Cairo University

Eligibility Criteria

Inclusion Criteria

  • women diagnosed with GDM

Exclusion Criteria

  • pre-gestational diabetes type 1 or type 2 diabetes mellitus, diagnosed as pregnancy induced hypertension before GDM

Outcomes

Primary Outcomes

effect of lifestyle modification among GDM on pregnancy outcome

Time Frame: from 28 weeks of gestational until the first 24hours postpartum

assessment of fasting blood sugar and random blood sugar for the postpartum GDM women and their neonatal in the first 24 hours postpartum by using (fasting blood sugar (FBS) and random blood sugar (RBS) measured with digital blood glucose monitoring by using test strips

Study Sites (1)

Loading locations...

Similar Trials